Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The bridge between two worlds: psychoanalysis and fMRI.
Marini S, Di Tizio L, Dezi S, Armuzzi S, Pelaccia S, Valchera A, Sepede G, Girinelli G, De Berardis D, Martinotti G, Gambi F, Di Giannantonio M. Marini S, et al. Rev Neurosci. 2016 Feb;27(2):219-29. doi: 10.1515/revneuro-2015-0031. Rev Neurosci. 2016. PMID: 26444349 Review.
Agomelatine reversal of escitalopram-induced apathy: a case report.
De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: marini s. Psychiatry Clin Neurosci. 2013 Apr;67(3):190-1. doi: 10.1111/pcn.12032. Psychiatry Clin Neurosci. 2013. PMID: 23581873 Free article. No abstract available.
The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review.
De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: marini s. CNS Neurol Disord Drug Targets. 2013 Mar;12(2):252-64. doi: 10.2174/1871527311312020012. CNS Neurol Disord Drug Targets. 2013. PMID: 23469841 Review.
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series.
De Berardis D, Fornaro M, Serroni N, Olivieri L, Marini S, Moschetta FS, Srinivasan V, Assetta M, Valchera A, Salone A, Martinotti G, Onofrj M, Di Giannantonio M. De Berardis D, et al. Among authors: marini s. J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):343-5. doi: 10.1176/appi.neuropsych.12110286. J Neuropsychiatry Clin Neurosci. 2013. PMID: 24247862
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole.
De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: marini s. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):30-7. doi: 10.2174/1872214807666131229125700. Recent Pat Endocr Metab Immune Drug Discov. 2014. PMID: 24372345 Review.
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: marini s. Curr Drug Targets. 2015;16(10):1094-106. doi: 10.2174/1389450116666150506114108. Curr Drug Targets. 2015. PMID: 25944011 Review.
462 results